← Evidence map

ArticlePharmacoEconomics2003

Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.

Michael Iskedjian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2003

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this papercites it

Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease. | OpenQuestion